Menu

The latest from Magnitude Biosciences

A fully-fledged pre-clinical contract services provider. 
Here’s what we’ve been up to along the way!

2 August 2021
Fat Staining Assay for Ageing Research

Take a look at our fat staining assay for ageing research which determines whether caloric restriction could be involved in your test compound's mode of action. Please fill in the form below to download our new Fat Staining Assay Data Sheet:

Read More
29 July 2021
Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand

Hannah Raddings (right) and Alana Mullins (centre) with Magnitude Biosciences Head of Experiments Michael Fasseas (left)  Durham, UK - July 29, 2021 Magnitude Biosciences, the world’s leading commercial lab services provider in using the nematode worm C. elegans to accelerate drug discovery and other research in the areas of the gut microbiome, ageing, and neurodegeneration, […]

Read More
26 July 2021
Could C. elegans be the key to slowing ageing?

Originally published in Health Tech World: https://www.htworld.co.uk/interviews/could-c-elegans-be-the-key-to-slowing-ageing/ Health Tech World spoke to Magnitude Biosciences about its groundbreaking work with C. elegans and how it is assisting biotechs in the development of drugs that can slow ageing and tackle age-related neurodegenerative diseases.  C. elegans is a tiny worm about a millimetre in length. It’s been used in research since […]

Read More
19 July 2021
Frontiers in Longevity: How do we slow human ageing?

How do we slow the process of Ageing? David Weinkove discusses learnings from the Clubhouse event "The Future of Longevity II"

Read More
15 July 2021
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research

Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the industrial drug discovery process

Read More
9 July 2021
Translating groundbreaking drug development ideas into therapies with worms: takeaways from the joint ELRIG and British Pharmacological Society 2021 meeting

Some fascinating ideas came out of the Translating Ideas Into Therapies meeting held June 30-July 1 2021 by ELRIG and the British Pharmacological Society

Read More
Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand
Hannah Raddings (right) and Alana Mullins (centre) with Magnitude Biosciences Head of Experiments Mi...Read More
Could C. elegans be the key to slowing ageing?
Originally published in Health Tech World: https://www.htworld.co.uk/interviews/could-c-elegans-be-t...Read More
Frontiers in Longevity: How do we slow human ageing?
How do we slow the process of Ageing? David Weinkove discusses learnings from the Clubhouse event "T...Read More
Translating groundbreaking drug development ideas into therapies with worms: takeaways from the joint ELRIG and British Pharmacological Society 2021 meeting
Some fascinating ideas came out of the Translating Ideas Into Therapies meeting held June 30-July 1 ...Read More
Unlocking the microbiome as a target for drug discovery using C. elegans
The human microbiome holds great promise for modern medicine but is still largely a mystery to scie...Read More
Magnitude Biosciences recognised in Developed in Durham as local success story
Magnitude Biosciences has been recognised by Developed in Durham....Read More
Magnitude Biosciences to attend Translating Ideas Into Therapies 2021 and the International C. elegans Conference in June 2021
June 2021 marks an exciting month as we see some of our C. elegans thought leaders speaking at key e...Read More
Holly and Maggie
A child, a worm, and a new era of drug discovery
This article will tell the story of how C. elegans enabled a life-changing effects drug therapy for ...Read More
The Magnitude Biosciences team
Magnitude Biosciences launches new website
Magnitude Biosciences, the world’s leading C. elegans Contract Research Organisation (CRO) and com...Read More
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
Biosciences spinout secures six-figure funding to create new North East jobs A spinout enterprise fr...Read More
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, P...Read More
Magnitude Biosciences announces new hires to support continued growth
Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading con...Read More
Magnitude Biosciences secures UK government Future Fund to expand its workforce.
Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs acr...Read More
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research
Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More
Magnitude Biosciences will be presenting at the online European Worm Meeting.
Magnitude Biosciences will be presenting at the online European Worm Meeting....Read More
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd.
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd. ...Read More
The Magnitude Biosciences team
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham Univ...Read More
Fat Staining Assay for Ageing Research
Take a look at our fat staining assay for ageing research which determines whether caloric restricti...Read More
Research on ageing leader Magnitude Biosciences expands its project delivery team to meet increased demand
Hannah Raddings (right) and Alana Mullins (centre) with Magnitude Biosciences Head of Experiments Mi...Read More
Could C. elegans be the key to slowing ageing?
Originally published in Health Tech World: https://www.htworld.co.uk/interviews/could-c-elegans-be-t...Read More
Frontiers in Longevity: How do we slow human ageing?
How do we slow the process of Ageing? David Weinkove discusses learnings from the Clubhouse event "T...Read More
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research
Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the ...Read More
Translating groundbreaking drug development ideas into therapies with worms: takeaways from the joint ELRIG and British Pharmacological Society 2021 meeting
Some fascinating ideas came out of the Translating Ideas Into Therapies meeting held June 30-July 1 ...Read More
Unlocking the microbiome as a target for drug discovery using C. elegans
The human microbiome holds great promise for modern medicine but is still largely a mystery to scie...Read More
Developing a System to Quantify Efficacy of Neurodegeneration Therapeutics Using Automated Monitoring of C. elegans
Check out our poster showing how we can quantify the efficacy of neurodegeneration models...Read More
C. elegans mobility decline
This video shows an automated method to quantify that decline developed by Magnitude Biosciences whi...Read More
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control sati...Read More
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans
The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in C....Read More
UK SPINE Recording
Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the...Read More
Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms i...Read More
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour
How large scale non-invasive imaging of C. elegans to enable reliable measurement of Agein...Read More
C. elegans Automated Imaging Platform
Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre-...Read More
C. elegans Automated Imaging in Drug Discovery
De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegen...Read More
An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.
An overview of the use of C. elegans in longevity research including the genetic manipulat...Read More
Magnitude Biosciences recognised in Developed in Durham as local success story
Magnitude Biosciences has been recognised by Developed in Durham....Read More
Magnitude Biosciences to attend Translating Ideas Into Therapies 2021 and the International C. elegans Conference in June 2021
June 2021 marks an exciting month as we see some of our C. elegans thought leaders speaking at key e...Read More
Holly and Maggie
A child, a worm, and a new era of drug discovery
This article will tell the story of how C. elegans enabled a life-changing effects drug therapy for ...Read More
The Magnitude Biosciences team
Magnitude Biosciences launches new website
Magnitude Biosciences, the world’s leading C. elegans Contract Research Organisation (CRO) and com...Read More
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
Biosciences spinout secures six-figure funding to create new North East jobs A spinout enterprise fr...Read More
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, P...Read More
Magnitude Biosciences announces new hires to support continued growth
Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading con...Read More
Magnitude Biosciences secures UK government Future Fund to expand its workforce.
Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs acr...Read More
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research
Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More
Magnitude Biosciences will be presenting at the online European Worm Meeting.
Magnitude Biosciences will be presenting at the online European Worm Meeting....Read More
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd.
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd. ...Read More
The Magnitude Biosciences team
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham Univ...Read More

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram